Millennium Management
NRX

Millennium Management’s NEPHROGENEX INC COM NRX Stock Holding History

Millennium Management’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-75,000
Closed -$498K – 3963
2015
Q2 		$498K Buy
+75,000
New +$570K ﹤0.01% 2638

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Millennium Management's NRX Position: Q3 2015 in Review

Millennium Management sold out of NEPHROGENEX INC COM (NRX) in Q3 2015, closing a stake of 75,000 shares — an estimated $498K sold.

Millennium Management first reported a position in NRX in Q2 2015 and held it in 1 quarter. The position peaked at $498K in Q2 2015. 13 funds tracked by Wall St. Rank hold NRX as of Q3 2015.

  • Millennium Management reported no remaining NEPHROGENEX INC COM position as of Q3 2015 after selling out during the quarter.
  • Millennium Management sold 75,000 NEPHROGENEX INC COM shares in Q3 2015, an estimated $498K.
  • Millennium Management first reported a position in NEPHROGENEX INC COM in Q2 2015 and held it in 1 quarter.
  • Millennium Management's NEPHROGENEX INC COM position peaked at $498K in Q2 2015.
  • 13 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.